Skip to main content

Table 1 Patients’ characteristics

From: Comparison of prostate size and anthropometric parameters between diabetic and non-diabetic Congolese patients who underwent transurethral prostate resection in the Democratic Republic of Congo

Variable

All patients

Diabetic group

Non-diabetic group

p

n = 159

n = 65

n = 94

Age (years)

68 ± 8.5

69.3 ± 8.1

67.13 ± 8.8

0.12

 

67 (62, 74)

69 (62, 76)

66 (62, 72)

 

IPSS

n = 159

n = 65

n = 94

 
 

26.8 ± 5.8

28.6 ± 4.3

25.6 ± 6.4

0.005w

 

27 (24, 32)

29 (27, 32)

27 (21, 31)

 

QOL

n = 159

n = 65

n = 94

 
 

6.2 ± 0.8

6.3 ± 0.7

6.2 ± 0.8

0.24w

 

6 (6, 7)

6 (6, 7)

6 (6, 7)

 

DS

n = 159

n = 65

n = 94

 
 

4.11 ± 3.1

4.2 ± 2.7

4.1 ± 3.3

0.38L

 

3 (2, 5)

3 (2, 6)

3 (2, 5)

 

PSA

n = 159

n = 65

n = 94

 
 

5.8 ± 4.9

5.8 ± 4

5.8 ± 5.5

0.4L

 

4 (3, 7)

4.2 (3.2, 4.2)

4 (2.7, 7)

 

FBG

n = 154

n = 65

n = 89

 
 

100.7 ± 35.7

121.7 ± 45.7

85.4 ± 11.7

< 0.001w

 

91.5 (81, 107)

110 (96, 131)

87 (76, 95)

 

BMI

n = 159

n = 65

n = 94

 
 

24.5 ± 3.4

23.6 ± 3.5

25.1 ± 3.3

0.008

 

23.5 (22, 26.7)

22.7 (21.7, 23.9)

24.7 (22.8, 27.5)

 

WC

n = 159

n = 65

n = 94

 
 

92.9 ± 10.5

90.6 ± 10.4

94.6 ± 10.3

0.018

 

91 (86, 96)

88 (85, 93)

94 (88, 98)

 

PV

n = 159

n = 65

n = 94

 
 

53.2 ± 22

58.5 ± 23.5

49.4 ± 20.3

0.027w

 

50 (35, 66)

60 (42, 71)

45 (33, 63)

 
  1. IPSS International Prostate Symptom Score (0–35), QOL quality of life score (1–7), DS duration of symptoms (years), BMI body mass index (kg/m2), WC waist circumference (cm), FBG fasting blood glucose (mg/dl), PSA prostate-specific antigen (ng/ml), PV prostate volume (cc)
  2. W Wilcoxon’s sum ranked test
  3. L statistical tests were run on log-transformed variables